Search
for
Sort by
Research 31–60 of 1000+
- A Real‐World Disproportionality Analysis of Avacopan in Anti‐Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Letter to the Editor: androgenetic alopecia; drug safety and therapeutic strategies
- Anti-programmed cell death protein 1-induced lichenoid changes of the nail unit: Histopathologic description
- Cellular therapeutics and immunotherapies in wound healing – on the pulse of time?
- Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Adverse Events in Isotretinoin Therapy: A Single-Arm Meta-Analysis
- Profile analysis of adverse events after boron neutron capture therapy for head and neck cancer: a sub-analysis of the JHN002 study
- Hypertension: sex-related differences in drug treatment, prevalence and blood pressure control in primary care
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Analysis of chemotherapy-induced peripheral neuropathy using the Japanese Adverse Drug Event Report database
- 9-cis-Retinoic Acid Capsules in the Treatment of AIDS-Related Kaposi Sarcoma
- Ultra-low dose estradiol and dydrogesterone for the treatment of menopausal symptoms in a pooled, multi-ethnic population
- Long‐term safety and efficacy of bimatoprost solution 0·03% application to the eyelid margin for the treatment of idiopathic and chemotherapy‐induced eyelash hypotrichosis: a randomized controlled trial
- Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia
- Limitations of Treatment-Induced Alopecia Grading Instruments in Evaluating Therapeutic Response
- Calcipotriene plus betamethasone dipropionate gel: a new combination therapy for scalp psoriasis
- Index
- LB1056 Phase 1b: Translational evaluation of VYN201, a pan-BD BET inhibitor, for the treatment of non-segmental vitiligo
- 468 Use of calcitonin gene-related peptide monoclonal antibodies in patients with rosacea: An exploratory, comparative case series
- Sodium selenate as a disease-modifying treatment for mild–moderate Alzheimer’s disease: an open-label extension study
- Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia
- Targeted Follicular Delivery via Liposomal Encapsulation of Sesbania grandiflora - Enhances Hair and Scalp Health: A Randomized, Double-Blind, Placebo-Controlled Clinical Study
- Targeted Follicular Delivery via Liposomal Encapsulation of Sesbania grandiflora - Enhances Hair and Scalp Health: A Randomized, Double-Blind, Placebo-Controlled Clinical Study
- Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial
- Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data
- Topical, light-based, and complementary interventions for acne: an overview of systematic reviews
- Predictive value of the serum albumin change rate for therapeutic response to targeted therapy in patients with AIDS-related non-Hodgkin lymphoma